文献速递糖尿病

外源性胰岛素抗体综合征所致低血糖:来自中国的大型单中心病例系列

Hypoglycemia Caused by Exogenous Insulin Antibody Syndrome: A Large Single-Center Case Series From China.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

该研究总结了中国单中心23例糖尿病患者中外源性胰岛素抗体综合征(EIAS)所致自身免疫性低血糖的临床特征,并对10例患者进行HLA基因分型。多数患者表现为高血糖与低血糖交替、高胰岛素自身抗体滴度及胰岛素/C肽摩尔比升高,自发缓解率超过70%。作者认为胰岛素自身抗体和胰岛素/C肽摩尔比是可靠的筛查指标。

要点

  • 超过90%的患者表现为高血糖与低血糖交替。
  • 多数患者胰岛素自身抗体滴度高(>90%),胰岛素/C肽摩尔比>7(>85%)。
  • 自发缓解率超过70%,胰岛素和胰岛素自身抗体监测可能有助于治疗有效性。

核心结论

  • EIAS所致自身免疫性低血糖的易感因素包括强烈的自身免疫背景。
  • 1型糖尿病或胰岛素自身免疫综合征的易感HLA基因型可能不能解释该病的易感性。
  • 胰岛素自身抗体和胰岛素/C肽摩尔比是可靠的筛查选项,该病预后良好。

研究设计与样本

  • 总结23例糖尿病患者中EIAS所致自身免疫性低血糖的临床特征。
  • 对10例患者进行人类白细胞抗原(HLA)基因分型。

主要发现

  • 自身免疫共病频率为21.7%,食物或药物过敏为48%,胰岛素过敏为30%,胰岛素注射部位脂肪营养不良为22%,抗核抗体阳性为25%。
  • 超过90%的患者观察到高血糖与低血糖交替。
  • 多数患者胰岛素自身抗体滴度高(>90%),胰岛素浓度不适当升高(胰岛素/C肽摩尔比>7,>85%)。
  • 与既往报道的1型糖尿病频率相比,DRB1*0405-DQB1*0401和DRB1*0901-DQB1*0303频率相似;与胰岛素自身免疫综合征相比,DRB1*0406频率较低。
  • 自发缓解率超过70%。

临床怎么用

  • 作者认为胰岛素自身抗体和胰岛素/C肽摩尔比是可靠的筛查选项。
  • 作者认为监测胰岛素和胰岛素自身抗体可能有助于治疗有效性。
  • 作者认为该病预后良好。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Exogenous insulin antibody syndrome (EIAS) can lead to unexpected and potentially life-threatening recurrent hypoglycemia. OBJECTIVE: We aimed to better define autoimmune hypoglycemia caused by EIAS in patients with diabetes and shed light on the improvements in the identification and intervention for this rare but possibly life-threatening condition. METHODS: We summarized the clinical characteristics of autoimmune hypoglycemia caused by EIAS in 23 patients with diabetes. Furthermore, we performed human leukocyte antigen (HLA) genotyping of 10 patients. RESULTS: We identified a high frequency of autoimmune comorbidities (21.7%), food or drug allergy (48%), insulin allergy (30%), lipodystrophy at the insulin injection sites (22%), and antinuclear antibodies (25%) in the patients. Alternation between hyperglycemia and hypoglycemia was observed in more than 90% of the patients. Most patients showed a high insulin autoantibody titer (>90%) and inappropriately increased insulin concentration (insulin/C-peptide molar ratio >7, >85%). We detected similar frequencies of DRB1*0405-DQB1*0401 and DRB1*0901-DQB1*0303 compared with previously reported frequencies in type 1 diabetes, and a lower frequency of DRB1*0406 compared with insulin autoimmune syndrome. The spontaneous remission rate exceeded 70%. CONCLUSION: Predisposing factors for autoimmune hypoglycemia caused by EIAS include a strong autoimmune background. Susceptible HLA genotypes for type 1 diabetes or insulin autoimmune syndrome might not explain susceptibility to this condition. Additionally, insulin autoantibodies and the insulin/C-peptide molar ratio are reliable screening options. The prognosis for this condition is favorable. Monitoring of insulin and insulin autoantibodies may contribute to treatment effectiveness.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Liu Y, Ping F, Yu J, et al. Hypoglycemia Caused by Exogenous Insulin Antibody Syndrome: A Large Single-Center Case Series From China. J Clin Endocrinol Metab. 2023. PMID: 36219196. doi:10.1210/clinem/dgac578

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。